Enzon Pharmaceuticals (ENZN) Stock Chart & Stock Price History $0.08 0.00 (-3.25%) As of 08/6/2025 03:40 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Enzon Pharmaceuticals Stock Price Performance The Enzon Pharmaceuticals (ENZN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.53%, with a year-to-date return of -50.48%. In the past month, the stock has decreased 25.67%, reflecting recent market activity. As of the latest close, Enzon Pharmaceuticals traded at $0.08 with a market cap of $5.74 million and volume of 700 shares. Five years ago, the stock traded at $0.23, representing a 66.46% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 183,817 shares. Receive ENZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.71%1 Month Performance-25.67%3 Month Performance-22.55%Year-To-Date Performance-50.48%1 Year Performance-54.53%5 Year Performance-66.46% ENZN Stock Chart for Thursday, August, 7, 2025 ENZN Chart by TradingView Enzon Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$0.08$0.08-3.25%$0.08$0.08700 shs$5.74 million08/05/2025$0.07$0.08+10.06%$0.08$0.0712,134 shs$5.93 million08/04/2025$0.08$0.07-4.47%$0.08$0.0748,756 shs$5.39 million08/01/2025$0.08$0.08-4.76%$0.08$0.0816,910 shs$5.64 million07/31/2025$0.07$0.08+17.87%$0.08$0.0741,677 shs$5.92 million07/30/2025$0.07$0.07+2.58%$0.08$0.0760,032 shs$5.02 million07/29/2025$0.08$0.07-12.93%$0.08$0.0781,568 shs$4.90 million07/28/2025$0.08$0.08-5.60%$0.09$0.0729,632 shs$5.63 million07/25/2025$0.09$0.08-7.27%$0.10$0.07447,972 shs$5.96 million07/24/2025$0.08$0.09+9.76%$0.10$0.092,743 shs$6.43 million Get the Latest News and Ratings for ENZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$0.09$0.08-7.39%$0.10$0.0835,232 shs$5.86 million07/22/2025$0.08$0.09+2.16%$0.10$0.0831,974 shs$6.32 million07/21/2025$0.09$0.08-1.88%$0.09$0.0827,941 shs$6.19 million07/18/2025$0.08$0.09+2.29%$0.10$0.0813,604 shs$6.31 million07/17/2025$0.09$0.08-8.08%$0.10$0.0781,309 shs$6.17 million07/16/2025$0.11$0.09-17.44%$0.11$0.0837,599 shs$6.71 million07/15/2025$0.10$0.11+9.50%$0.11$0.1066,001 shs$8.13 million07/14/2025$0.10$0.10+3.95%$0.11$0.097,114 shs$7.42 million07/11/2025$0.10$0.10-1.33%$0.11$0.0922,794 shs$7.14 million07/10/2025$0.10$0.10-2.50%$0.11$0.0932,665 shs$7.24 million07/09/2025$0.11$0.10-9.09%$0.11$0.10110,301 shs$7.42 million07/08/2025$0.10$0.11+5.77%$0.11$0.0972,681 shs$8.16 million07/07/2025$0.11$0.10-9.49%$0.11$0.0971,991 shs$7.72 million Related Companies SABS Stock Price Chart CRIS Stock Price Chart BOLT Stock Price Chart AFFY Stock Price Chart AMGN Stock Price Chart GILD Stock Price Chart VRTX Stock Price Chart REGN Stock Price Chart ALNY Stock Price Chart BIIB Stock Price Chart Receive ENZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ENZN) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZN Stock Alerts